RedefiningHealthcare Agility

Jose Almeida

Chairman,
President, CEO
Baxter

José (Joe) E. Almeida is chairman, president and chief executive officer of Baxter International Inc.

Every day, millions of patients and caregivers rely on Baxter’s broad portfolio of essential healthcare products, which can be found in dialysis centers, homes, clinics and innumerable hospitals worldwide.

Almeida assumed his current responsibilities at Baxter in January 2016. He is now leading the company through a period of dynamic transformation powered by accelerated innovation, operational excellence and strategic execution.

Prior to joining Baxter, Almeida was chairman, president and CEO of Covidien plc from 2012 through 2015. He previously served as president of Covidien's Medical Devices organization, and in several senior leadership roles at Covidien's predecessor, Tyco Healthcare. He has also held leadership positions at Wilson Greatbatch Technologies, American Home Products' Acufex Microsurgical division, and Johnson & Johnson's Professional Products division.

Almeida is a member of the board of directors of Walgreens Boots Alliance, Inc. He also serves on the board of trustees of Partners in Health.

A native of Brazil, Almeida received a Bachelor of Science degree in mechanical engineering from Instituto Mauá de Tecnologia.

Harjit Gill

Chief Executive Officer
APAC MED

Harjit was appointed CEO of APACMed in February 2019. Founded in 2014, the Asia Pacific Medical Technology Association is the only regional association to provide a unified voice for the medical technology industry in Asia Pacific.

She was formerly EVP and CEO of Philips ASEAN & Pacific until October 2015. In this role, she managed a team of 10,000 people in 10 countries across its Healthcare, Lighting and Consumer Lifestyle sectors. Harjit spent over two decades with Philips holding a variety of international roles in General Management in England, Holland, Singapore, Dubai and Hong Kong.

Passionate about innovation and healthcare reform, she holds concurrent positions on several prestigious boards:

• Board Member, ResMed, a pioneer in cloud connected, innovative solutions, for people with sleep apnea, COPD, and other chronic respiratory diseases
• Board Member, MAS Holdings, South East Asia’s largest manufacturer of apparel and textiles
• Board Member, Apollo Education, a leading English Education provider in Vietnam
• Advisor, Delmedica, an innovative Singapore-based company that has developed the X-Halo, the world’s first breath thermometer for managing respiratory diseases.

She is a former Singapore Chapter Chair of the Young Presidents Organisation, the premier leadership organisation of Chief Executives in the world, and former Board member of the SICC, National University of Singapore Entrepreneurship Committee and World Economic Forum Global Agenda Council on South East Asia. Harjit has spoken at several global leadership platforms including the World Economic Forum, INSEAD and IMC on Innovation and Healthcare.

Andrew Frye

Senior Vice President & President, APAC
Baxter Healthcare
Chairman APACMed

Andrew Frye is senior vice president and president, APAC, for Baxter Healthcare and is the current Chairman of the Board of Directors for APACMed.

Andrew joined Baxter in 2017 from DKSH Holdings Ltd., where he served as Global Head of Healthcare from 2015 to 2017. In that role, he oversaw a portfolio of pharmaceuticals, over-the-counter and device products across 13 countries. Previously, he served as vice president of Business Development from 2011 to 2014 for DKSH Healthcare. Earlier in his career, he held a number of commercial roles with increasing responsibility at Abbott Laboratories’ Pharmaceutical and Nutrition divisions.

Andrew received a bachelor’s degree in psychobiology from the University of Southern California and master’s degree in marketing from the Anderson School of Management at the University of California. He resides with his family in Singapore.

Kevin Lobo

Chairman & CEO Stryker,
Chairman ADVAMED

Ashley McEvoy

Executive Vice President,
Worldwide Chairman, Medical Devices
Johnson & Johnson

Ashley McEvoy is Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson and a member of the Executive Committee. In her role, Ashley leads the surgery, orthopaedics, interventional solutions and eye health businesses, which generate approximately $26B in revenue. Ashley oversees 70,000 employees across Ethicon, DePuy Synthes, Biosense Webster and Johnson & Johnson Vision.

Ashley inspires her teams to disrupt medical interventions to meet the needs of patients around the world. She spearheaded the acquisition of Auris Health in 2019 to accelerate the company’s entrance in robotics with a platform that is commercially available in the U.S. Under her leadership, there have been more than $6.5B in acquisitions and strategic collaborations in Medical Devices, representing 50 different deals to enable growth and address unmet patient needs.

She is a Credo-based leader who has delivered above-market performance for all four multi-billion-dollar, global companies she has led, and she is particularly adept at designing turnaround strategies for mission critical businesses. She advances diversity and inclusion to enable forward-thinking teams who can deliver results and drive industry change.

Her accomplishments have been recognized by numerous business and philanthropic organizations and she was named to Fortune magazine’s 2019 list of the “Most Powerful Women.”

Graham McLean

President, APAC
Stryker
Vice-Chairman, APACMed

Stryker has a long and proud record of leadership, commitment and support for the Medical Technology industry in Asia Pacific. Stryker operates in a very broad range of MedTech sectors including theatre and hospital equipment, beds, surgical consumables, neuro technology and orthopaedic implants (maxillio- facial, spine, joints and trauma).

Graham has worked for Stryker for 14 years with extensive experience across Asia Pacific. Graham’s current role is President Asia Pacific and he sits on the Stryker global Executive Leadership team.

Graham was formerly President of Stryker Australia/New Zealand and sat on the MTAA Board for 3 years, then President of Stryker Japan and sat on the AMDD Board for 2 years. He has front line experience of the challenges and issues in key markets in the region. Graham offers a unique set of skills and experience including 20 years of leadership in food and drinks businesses, consulting, as well as MedTech. He has governance experience, having worked closely with public listed company boards and voluntary organizations, is a member of the Institute of Company Directors and a qualified accountant.

James Lim

Executive Vice President & President, Greater Asia
Becton Dickinson
Treasurer, APACMed

James Lim, Executive Vice President and President, Greater Asia for Becton Dickinson (BD), sits on BD’s Global Leadership Management Committee reporting to the CEO. Based in Singapore, BD’s regional headquarters, James leads the business operations in China, Japan, Taiwan, Hong Kong, Australia, and New Zealand, Korea, SEA, India and Pakistan.

James joined BD in 1994 from Seagate International. Starting as an Engineering and Facility Manager for BD Medical (Singapore), after a 3-year assignment in R&D, he became a Plant Manager in 2000. In 2003, he was promoted to the role of the Director of Operations for Asia Pacific, where he was responsible for the regional manufacturing and supply chain functions, overseeing plants operating in Singapore, Bawal, India, and Suzhou, China.

In April 2008, James was appointed as the Vice President for Central and Asia Pacific, holding responsibility for the Central Asia Business Management and support functions for the entire Asia Pacific region.

Four years later, James was appointed as President of Greater Asia and an Executive Member of the company, becoming the first Asian leader to take office in the region’s 30-year history.

A strong believer in developing and retaining the best of talents, James was conferred the Leading CEO award by the Singapore Human Resources Institute (SHRI) in 2014. The award was testimony to his championship of innovative and effective HR ideas and practices and demonstration of leadership commitment to talent development within the industry.

James received his early education in Malaysia and continued to study the National University of Singapore, where he graduated with a Mechanical Engineering degree.

Married and with two teenage sons, James tries to spend as much time as possible with them between his business travels. He is passionate about automotive and is an avid fitness enthusiast.

Ian Burgess

Chief Executive Officer
Medical Technology Association of Australia (MTAA)

Ian is CEO of the Medical Technology Association of Australia, the national association representing companies in the medical device industry.

Ian is a director of the Asia Pacific Medical Technology Association, which is headquartered in Singapore, and is also a director and Vice Chair of Red Nose, formerly known as SIDS & Kids, a well-respected not-for-profit organisation that is dedicated to saving the lives of babies and children.

Art Butcher

Executive Vice President & President, Asia Pacific
Boston Scientific

Art Butcher is Executive Vice President and President for Boston Scientific in the Asia Pacific region, a role he has held since February 2020. Currently based in Singapore, Art is responsible for overseeing the continued growth of our business across Asia Pacific in line with our company values. He is a member of the Boston Scientific global executive committee.

Art has been with Boston Scientific for over 20 years. Prior to his current role, Art was President, Endoscopy with global responsibility for developing and bringing to market less invasive devices for treating gastrointestinal and pulmonary conditions. He was previously Vice President and General Manager, Endoscopy in Japan.

Art has held a variety of marketing and strategic planning management positions within the Endoscopy, Urology and Pelvic Health businesses, including Vice President of Global Marketing (Endoscopy) and Vice President of New Business Development and Strategic Planning (Urology and Women’s Health). He joined Boston Scientific in 1997 as a sales representative in the Urology business.

Art holds a BA in International Relations from the University of Pennsylvania and an MBA from Columbia University.

Probir Das

Chairman & Managing Director
Terumo Asia Holdings

Probir has three decades of medical technology industry experience and has extensively worked across medical-surgical, interventional, clinical diagnostics, infectious diseases, ophthalmology, and nutrition domains.

Probir has been with Terumo Corporation since 2012 and is currently responsible for overseeing its operations across Asia Pacific and India. As the Regional Leader of Asia Pacific & India, he spearheads Terumo’s investments into these emerging markets for purposeful talent and business strengthening, health system scaleup through various skill interventions, and driving the long-term strategy of Terumo in Asia Pacific.

Given his keen interest in policy shaping, Probir is actively engaged in advocacy and sits on the Board of Directors for the Asia Pacific Medical Technology Association (APACMed) and Medical Technology Association of India (MTaI). Probir also has over a decade’s teaching experience, specifically around strategy, leadership development, coaching and performance management. His passion towards MedTech sees him mentor start-ups and entrepreneurs.

Probir resides in Singapore and is a frequent visitor to all of the Asia Pacific markets and Japan.

Probir Das leads all of Terumo’s (leading global medtech corporation) business operations across Asia Pacific and India. He has 20 years of medtech leadership experience across Asia, along with 10 years of teaching experience with BD University and Terumo India Learning Council.

He is a board member of APACMed and a founding board member of MTaI. Probir previously held leadership positions at FICCI & NATHEALTH. His intense passion about healthcare ecosystem sees him support and mentor several entrepreneurs and start-ups.

Lam Chee Hong

President, Asia Pacific
B. Braun

Lam Chee Hong is the President and a Member of the Management Board of B. Braun Asia Pacific. As President, he is responsible for the Group’s pharmaceutical and medical technology business across the region.

Chee Hong begin his career with B. Braun in 1986 as a medical sales representative. In recognition of his leadership, versatility and business performance, he was continually entrusted with additional key responsibilities and ascended through the levels in the organisation to assume the most senior leadership role in B. Braun Asia Pacific.

Based in B. Braun’s regional headquarters in Penang, Malaysia, he also oversees B. Braun Group’s largest production sites in the world with over 7,700 employees.

Chee Hong graduated with a Bachelor of Economics from the University of Malaya. He is married and has two children.

Dr Bernd Montag

CEO
Siemens Healthineers

Bernd Montag, Ph.D., has been CEO of Siemens Healthineers since February 2015. As of March 2018, the company is listed on the Frankfurt Stock Exchange as Siemens Healthineers AG (SHL). Three months after its stock market debut, Siemens Healthineers entered the technology index TecDAX and in September that year Deutsche Börse also included the company in the mid-cap index MDAX.

Bernd Montag joined Siemens in 1995. He held positions in corporate quality management and sales in the hearing aid division before moving to imaging systems in 1999, where he served as a product manager for computed tomography and as the head of marketing for magnetic resonance business. In 2004, he assumed overall responsibility for computed tomography, and in 2008, he was named President of the Imaging & Therapy Division, which combined the overall business of diagnostic imaging and image-guided therapies.

Bernd Montag completed his studies in Physics at the Friedrich-Alexander-University, Erlangen-Nuremberg, and earned a Ph.D. in theoretical multi-particle physics. He was born in Munich, Germany, in 1969.

Chris Lee

Senior Vice President &
President, Asia Pacific
Medtronic

Chris Lee is Senior Vice President and President of Medtronic, Asia Pacific (APAC) and serves as a member of the Medtronic Executive Committee. He oversees the Medtronic APAC region where the company has presence in more than 20 countries with about 10,000 employees across the region. Chris joined Medtronic in 2012 as President of the Greater China region and was named as President of APAC in December of 2017. Under his leadership, the Greater China region achieved five consecutive years of double-digit growth by bringing meaningful innovation and expanding access to more patients locally.

Chris has a strong track record of global leadership in the healthcare industry — both in pharmaceutical and medical technology. He is known for his inclusive leadership style, commitment to meritocracy, and proven business success. During his time in China, Chris developed strategic partnerships with the Chinese government and was a strong supporter of corporate social responsibility — leading the company’s effective relief efforts to respond to the Lushan earthquake in Sichuan Province.

Prior to Medtronic, Chris was Regional Head and Senior Vice President, APAC at Bayer HealthCare where he was responsible for overall operations in the region, including pharmaceuticals, consumer over-the-counter, animal health, and medical devices. Chris has also held roles of increasing responsibility in several multinational companies, including Bristol Myers Squibb and Merck Sharpe and Dohme, while based in APAC and the U.S., respectively.

Chris is a pioneer in the management of workplace happiness and is the author of two bestselling books, one on emotional management and one on marketing. He was also formerly an executive director in the pharmaceutical industry associations of China (RDPAC), Australia (Medicines Australia), and Korea (Korea Pharma).
Chris serves on the board of the Asia Pacific Medical Technology Association (APACMed).

Chris holds a bachelor’s degree from the University of Arizona, Tucson and a master’s degree from the American Graduate School of International Management (Thunderbird). He is fluent in English and Korean, with a good understanding of Mandarin Chinese and Japanese.

Lance Little

Managing Director,
Region Asia Pacific
Roche Diagnostics Asia Pacific

Lance Little became the Managing Director, Region Asia Pacific for Roche Diagnostics in 2012. Prior to that, he was the Managing Director of Roche Diagnostics India (including the Indian sub-region). His experience as Managing Director extends to both Roche Diagnostics Thailand and Roche Diagnostics New Zealand.

Lance joined Roche in New Zealand in 1995 in the technical support and management division of Boehringer Mannheim’s Clinical Chemistry portfolio, before moving on to sales and marketing roles. He was appointed Managing Director of Roche Diagnostics Thailand in 2008 before returning to New Zealand to take up the role of Managing Director in 2009.

Lance started his career as a Medical Laboratory Scientist, specialising in Biochemistry at Auckland Hospital Laboratory in New Zealand. Following that, he spent some time managing the Automation Laboratory at Diagnostic Laboratories in Auckland.

Ashraf Hanna

COO
Verily

Ashraf Hanna is the Chief Operating Officer of Verily.

Previously he was the CEO of ORIC Pharmaceuticals, a company focused on the development of treatments for cancer resistance. Before that, Ashraf spent nearly 11 years as a Vice President at Genentech leading the Commercial and Medical Affairs Finance functions, as well as Alliance Management and Portfolio Planning group, which is responsible for developing metrics and guiding R&D investments.

Ashraf was also the CFO for the Genentech foundation, and previously at McKinsey and Company. He is a graduate of University of Chicago, has a Ph.D. in Physics from Harvard University and an M.D. from the University of Massachusetts.

John Groetelaars

President & CEO
Hillrom

John P. Groetelaars is President and Chief Executive Officer of Hillrom since May 2018.

Mr. Groetelaars most recently served as Executive Vice President and President of the Interventional Segment at Becton, Dickinson and Company, since December 2017 following its acquisition of C.R. Bard where his responsibilities included global strategic, financial, operational and innovation platforms.

He previously served in a variety of progressive roles at C.R. Bard during his 10-year career there, including as a Group President from 2015 to 2017. Mr. Groetelaars joined C.R. Bard in 2008 as Vice President and General Manager, Davol Inc., and was appointed President of Davol in 2009.

In 2013, Mr. Groetelaars was promoted to Group Vice President and in 2015 he was promoted to Group President, a position he held until C.R. Bard was acquired by Becton, Dickinson and Company in December 2017.

Prior to joining C.R. Bard, Mr. Groetelaars held various international leadership positions in Canada, Denmark and the UK at Boston Scientific Corporation from 2001 until 2008. Prior to joining Boston Scientific, Mr. Groetelaars held positions in general management, marketing, business development and sales with Guidant Corporation and with Eli Lilly.

Mr. Groetelaars serves as an Executive Director on Hillrom’s board, is Director of the ADVAMed board and is a member of The Economic Club of Chicago. Mr. Groetelaars earned his bachelor’s in Mechanical Engineering from Kettering University in Michigan, and an MBA from Columbia University in New York.

Sanjay Prabhakaran

Regional President,
Asia Pacific
Hologic

Sanjay Prabhakaran joined Hologic in July 2016 with more than 25 years of experience in medical devices, diagnostics and biotechnology across the Asia Pacific region.

Mr. Prabhakaran worked at Baxter International from 2007 to 2016, most recently as President, Asia Pacific, where he oversaw a commercial and manufacturing footprint exceeding $2 billion in sales with over 12,000 employees. From 1997 to 2006, Mr. Prabhakaran worked at Boston Scientific in senior leadership roles. He began his career at Boehringer Mannheim GmBH in India.

He is a member of the board of APACMed and has previously been a board member of AdvaMed in China, and has helped build government partnerships across the region.

He received a Bachelor of Technology degree in Electronics and Communication from Calicut University, and graduated from Harvard Business School’s Advanced Management Program.

Tim Schmid

Company Group Chairman, Medical Devices, Asia Pacific
Johnson & Johnson

Tim Schmid is the Company Group Chairman, Johnson & Johnson Medical Devices, Asia Pacific where he leads the company’s efforts to bring market leading surgical, orthopedic and interventional solutions to patients in need across Asia.

Tim has been with Johnson & Johnson for over 25 years and has held diverse leadership positions in sales, strategic marketing and general management across multiple businesses and geographies. Most recently, he served as Chief Strategic Customer Officer, where he led a transformation of Johnson & Johnson’s business-to-business relationships with hospital systems in the US. Prior to this he was President of Johnson & Johnson’s surgery business, Ethicon, where led a major turnaround in the US. This included the integration of five standalone businesses and the implementation of a new go-to-market model to address the rapidly changing needs of both clinicians and health care administrators.

Tim is a global executive who, in addition to leading business transformations across multiple continents, builds strong teams that have a track record of customer orientated solutions, growth and leadership across the medical technology industry. He is a champion for the value of diversity, currently leading the company’s diversity and inclusion efforts across Asia Pacific. He was also instrumental in establishing Johnson & Johnsons global partnership with Operation Smile, focused on bringing safe and effective surgical care to children suffering from cleft lip or cleft palate.

Educated in South Africa, Canada and the United Kingdom, Tim has lived and worked in six countries on four continents. He earned his undergraduate degree from the University of Western Ontario in Canada, and an MBA from Richmond University in the United Kingdom.

Elisabeth Staudinger

President, Asia Pacific
Siemens Healthineers

Elisabeth is President for Siemens Healthineers in the Asia Pacific region and is currently based in Shanghai, China.

Elisabeth joined Siemens in 1998 and held several roles with increasing responsibility spanning from procurement, strategy, manufacturing and R&D, and global CEO of the Refurbished Systems Business of Siemens Healthineers.

She moved to Asia in 2013 to lead the business of Siemens Healthineers across the entire portfolio spanning from Diagnostic Imaging, Laboratory Diagnostics, and Advanced Therapies in Asia Pacific. Her mission is to provide access to care and enable healthcare providers to increase value by making medicine more precise, changing the way care is delivered, improving the patient experience, and digitalizing healthcare.

Elisabeth studied in Vienna, Nanjing, and Beijing and holds a master’s degree in Economics from the Vienna University of Economics and Business as well as a master’s degree in Sinology from the University of Vienna. She is married and has one son.

Paul Tan Minjie

Divisional Vice President, APAC
Abbott

Julie Tay

Senior Vice President & Managing Director
Align Technology

Julie Tay is Senior Vice President and Managing Director, Asia Pacific, responsible for Align Technology’s market development and operational execution of all Align Technology products and services in the Asia Pacific region. She is also a member of the Executive Management Committee. She joined the company in March 2013 originally as Vice President and Managing Director, Asia Pacific.

Ms. Tay has more than 20 years’ experience in international management of various segments including consumer healthcare, medical devices and chemical businesses across Asia.

Prior to joining Align Technology, Ms. Tay was regional head of Bayer Healthcare (Diabetes Care) overseeing operations across Asia where she grew the business into a sustainable and profitable operation in three years. Prior to Bayer, Ms. Tay spent 15 years with Johnson & Johnson Medical where she was instrumental in establishing the LifeScan franchise within Asia.

Ms. Tay holds an M.B.A. from Curtin University of Technology (Australia) and a B.A. degree from the National University of Singapore.

Sunil Vasanth

Vice President, Surgical,
Asia Pacific
Alcon

Sunil Vasanth is currently Vice President, Surgical, Asia Pacific with Alcon. In his past four years with Alcon and Novartis, Sunil has held roles of increasing responsibility across the region. These have included country leadership (India), cluster leadership (India and South East Asia) and leading the Asia Pacific region with Alcon.

Alcon is the world’s leading eye care company, with excess of $7Bn in sales in its surgical and vision care business.

Sunil joined Alcon in March 2016 from Johnson & Johnson where he spent 21 successful years across a range of leadership roles in commercial and general management across India, Asia Pacific and the United States.

He was worldwide head of Global Strategic and International marketing for Johnson & Johnson’s Neuro business based in Boston, USA.

Sunil is passionate about improving standards of care globally and providing access to medical technologies especially in emerging countries.

Sunil has served on the board of Medical Technology Association of India (MTaI) as well as the executive committee of AdvaMed India.

Sunil holds both an electrical engineering degree and MBA from the University of Mumbai and has post-graduate certifications from IMD Business School and Harvard Business School.

Paul Grand

Chief Executive Officer
Medtech Innovator

Paul Grand is the founder and CEO of MedTech Innovator, the largest accelerator of medical devices in the world. The nonprofit accelerator seeks to improve the lives of patients by advancing companies poised to transform the healthcare system.

Prior to MedTech Innovator, Paul was a serial entrepreneur starting companies in the biopharma, medtech, and tech industries. He became a venture capitalist in 2005, when he joined RCT Ventures, an early-stage life science investor where he served as Managing Director. At RCT, Paul focused on medtech investments and sourcing innovation. He founded MedTech Innovator as a program within RCT Ventures in 2013 and left to run MedTech Innovator as a stand-alone company with RCT's support in 2016.
Paul has interacted with thousands of medical technology startups as part of MedTech Innovator’s rigorous review process to identify the most promising early-stage companies in the industry. Over 340 companies are now in MedTech Innovator’s portfolio, collectively bringing 54 products to market with a combined total of over $1.8B in follow-on funding.

Fredrik Nyberg

Managing Director,
Asia Pacific MedTech Innovator

Fredrik is the Managing Director Asia Pacific at MedTech Innovator, based in Singapore. He was most recently the Founding CEO of Asia Pacific Medical Technology Association (APACMed).
Fredrik brings over 30 years of healthcare industry experience, 25 of which were spent in Asia-Pacific. He has held senior sales/ marketing, general management and strategic consulting positions. Fredrik serves as Board Member and advisor to several healthcare startup ventures and is a frequent speaker on the healthcare industry in Asia-Pacific. He holds a BSc from Gothenburg University, Sweden, and an MBA from Henley Management College, UK.

Stephanie Domas

Executive Vice President
MedSec

Stephanie Domas is the Executive Vice President of MedSec, a healthcare cybersecurity company exclusively focused on the unique challenges of protecting medical devices.
She leads the development of products and services to support medical device manufactures build more secure medical devices as well as healthcare delivery organizations and manage the risk of connected medical devices in healthcare environments.

Niko Skievaski

President & Co-Founder
Redox

As President and Co-Founder of Redox, Niko Skievaski leads his team in helping healthcare organizations fulfill the promise of digital health – resulting in better patient outcomes and efficiencies for healthcare providers. In this role, he was named to Forbes 2017 30 Under 30 list of visionaries reinventing healthcare. He hosts The Redox Podcast and interviews leaders from across digital health.

Prior to founding Redox, Skievaski worked at Epic, one of the largest health tech companies in the world, and as an entrepreneur, economics lecturer, and advisor to startups. After Epic, he co-founded 100state (Wisconsin’s largest co-working community) and created ICD-10 Illustrated – a satirical book illustrating medical billing codes. Skievaski has an MA degree in economics from Boston University and a B.S. degree in economics and international business from the Arizona State University’s W.P. Carey School of Business. He lives in Boulder, Colorado, USA with his partner, toddler, and collection of mountain bikes.

Dr. Indu Bhushan

Chief Executive Officer
National Health Authority (NHA)

Dr. Indu Bhushan serves as the Chief Executive Officer (CEO) of Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB - PMJAY) and the National Health Authority (NHA), Government of India. Dr. Bhushan is an ex-Indian Administrative Service (IAS) officer of the Indian Civil Services, 1983 Rajasthan cadre. He holds a Doctorate in Health Economics and a Master of Health Sciences from the Johns Hopkins University, USA. He is an alumnus of the prestigious Indian Institute of Technology- Banaras Hindu University (IIT BHU) and IIT Delhi where he completed his B. Tech and Post-Graduate Diploma, respectively. He is also a Chartered Financial Analyst (CFA).

Dr. Bhushan is a bureaucrat-turned-economist with a career spanning 35 years across a multitude of sectors. He served for nine years in the IAS prior to leaving government service. Thereafter, he worked as Senior Economist with the World Bank Group prior to moving to ADB.

Until his appointment as CEO, AB - PMJAY, he served as Director General, East Asia Department of the Asian Development Bank (ADB). He has held multiple positions within ADB including Director General, Strategy and Policy Department and led ADB’s engagement with the People's Republic of China (PRC), Hong Kong, Republic of Korea, Mongolia, and Taiwan including management of $12.6 billion portfolio comprising of 113 projects.

Dr. Bhushan administered and provided oversight to sectors like energy, environment, natural resources and agriculture, transport, public management, financial sector and regional cooperation, urban and social development. He also supervised ADB’s resident missions in the People’s Republic of China and Mongolia. Dr. Bhushan lives in an empty nest in New Delhi, with his wife, Anjana, an ex-IAS officer, and works with the World Health Organisation (WHO). He has two daughters, Devika and Ambika, who are both medical doctors and live in the USA. He likes to play bridge and catch the latest movies and theatrical shows on the weekend.

Lesley Maloney

Head of US Regulatory Policy & Global Policy Lead for Digital Health
Roche Diagnostics

Lesley R. Maloney, Pharm.D., is Head, U.S. Regulatory Policy for Roche Diagnostics. In that role, she is responsible for guiding Roche Diagnostics’ regulatory policy efforts in the United States. In addition, she is also responsible for global regulatory policy efforts related to digital health.

Prior to joining Roche Diagnostics, she worked for the U.S. Food and Drug Administration in the Office of the Commissioner, where she served in various roles, including Deputy Chief of Staff, Senior Policy Advisor, and Deputy Associate Commissioner for External Affairs. Dr. Maloney holds a doctor of pharmacy degree from the University of Oklahoma and did an Executive Residency in Association Leadership and Management at the American Society of Health-Systems Pharmacists.

Vibhav Garg

Director, Government Affairs Strategy,
India & ASEAN,
Boston Scientific

Mr. Vibhav Garg serves as the Director-Govt Affairs Strategy for India, India HUB & ASEAN and Head-Govt Business, India & India HUB for Boston Scientific. He has extensive global experience of over 19 years in the areas of Policy Advocacy, Brand Management, Regulatory & Compliance, Public Affairs, Corporate Communications, Crisis Management and has been engaging with state and federal government of India, South Asian, South East Asian and other developing countries for various strategic healthcare initiatives and policy discussions with concerned stakeholders.

Prior to rejoining Boston Scientific , Vibhav held various strategic positions with US & India headquartered organizations like GE Healthcare as Vice President-Health Policy & Govt Affairs, Boston Scientific India as Associate Director-Health Economics & Govt Affairs; Confederation of India Industry, the apex industry body in India, as Head of Life Sciences & Healthcare; Mascon Global Limited, a boutique management and IT consulting organization, spearheaded their healthcare and life sciences initiatives in India and US as well; and Brainwave Biosolutions Ltd where he lead the life sciences and healthcare practice of the organization. Most recently he was associated with Indian Pharmaceutical Alliance, the pharma trade association, as Associate Secretary General.

He is a pharmacy graduate from GJU, Hissar followed by Master of Engineering in Biotechnology from BITS, Pilani and Advanced Diploma in Business Administration from All India Management Association. He is currently pursuing Doctorate in Business Administration & General Management with specialization in Health Policy/Economics. His thoughts, views and research have been published in various peer reviewed journals and magazines and he has delivered many national and international invited lectures. Vibhav is currently Industry Co-Chair in Asian Harmonization Working party (AHWP) representing Indian Medical Device Industry and also chairing the Medical Equipment Subgroup of CII (Confederation of Indian Industry), in addition to being Co-Chair of FICCI Medical Device Policy Committee and Lead for UHC working group of APACMed India CoE. He was also the Vice Chair of AdvaMed (Advanced Medical Technology Association) in India and currently heads multiple other committees in trade associations like CII, FICCI, AmCham and other industry associations. He has also been advising various departments in different ministries of Government of India like Department of IT, Health, and Biotechnology in various capacities.

Florian Then

Partner
McKinsey & Company

Torben Minko

Managing Director
B. Braun Vietnam Co., Ltd

Torben has been on assignments in Asia Pacific for over 10 years, since 2015 based in Vietnam. In his current position as Managing Director B.Braun Vietnam Co., Ltd. he is overseeing one of the largest German FDI with more than 1,400 skilled employees, two production facilities in Hanoi as well as sales and marketing office in HCMC. Over the last years, he has obtained a deep understanding about the business, political and bureaucratic environments in Vietnam where as his current position provides an exclusive insight about the healthcare system advantages and challenges.

Torben is active in the Vietnamese healthcare community and advocacy as Chairman of the Medical Device and Diagnostic Sector Committee (MDD) under EuroCham representing therewith 26 international member companies counting for more than 80% of the Vietnamese Medical Device market. Further to that, he is founding and board member of the International Quality Medicine Sector Committee (IQMed) under EuroCham representing viewpoints of European off-patent (generic) pharmaceutical companies.

Since 2019 Torben is Vice-Chairman of the German Business Association (GBA) actively representing German viewpoints and interests.

Since 2020 Torben is Board Member of the European Chamber of Commerce (EuroCham) promoting European sustainable investment and trade for more than 1,000 member companies.

Torben is based in Hanoi where he is living with his wife and two kids.

Danny Risberg

President,
Representative Director
Baxter Limited, Japan

Danny Risberg is General Manager of Baxter Limited. Danny joined Baxter in September 2018 after he served as the Chairman and CEO of Philips Japan for 10 years working across the Philips business sectors of HealthTech, Consumer and Lighting. He is well-experienced in medical device industry and has lead several industry groups in the medical and business sectors as former Chairman of the European Business Council Medical Equipment Committee and as the Chairman of the European Business Council (EBC) in Japan.

Prior to Philips Japan, Danny worked several years as a VP and CEO a for Fuji Respironics as the leader of their Asian operations. After a successful career helping its business gain a leading position in Japan and Asia Pacific, the Respironics group was acquired by Philips where Danny continued his efforts within the Philips Global organization. Danny is a Yale University Business Management (LEAP) program graduate. Born and raised in the US, he has 30 years of extended work and living experience in Japan, is fluent in Japanese. Danny enjoys fly fishing, cars and driving and enjoying time with his family in Tokyo.

Sujay Mashry

Vice President &
Managing Director, Asia Pacific & Japan
Livanova

Sujay Mashru is Vice President & Managing Director, Asia Pacific & Japan for LivaNova. In 2018, he relocated to Singapore from London and is responsible for overseeing the rapid expansion of the business in more than 20 countries across the region.

He joined LivaNova (previously Sorin Group) in 2012 as Director, Corporate Strategy & Business Development based in both London, UK and Milan, Italy where he was focused on corporate strategic planning, mergers and acquisitions and driving other strategic initiatives focused on business model innovation.

In 2015, he was promoted to Vice President, Commercial Operations for Eastern Europe, Middle East, Africa, Latin America and Asia Pacific where he was responsible for overseeing business transformation projects, commercial strategy, channel partner management and commercial excellence for all business units.

Prior to joining LivaNova, he spent 8 years with Medtronic in its Cardiac Rhythm Disease Management division in various sales, marketing and field engineer roles across the US.

He holds a Bachelor of Science degree in Electrical Engineering from Purdue University and an MBA from INSEAD.

Zhou Hui

Chairman
CCCMHPIE

Mr. Zhou Hui is the President of China Chamber of Commerce for Import & Export of Medicines & Health Products since November 2016. Before joining the Chamber, he used to be the Deputy Director General of the Department of Foreign Trade of Ministry of Commerce(MOFCOM).

From 2006 to 2015, he served consecutively as the Chinese Commercial Counsellor to Israel and Chinese Minister Counsellor to Indonesia. During the past 30 years, he has extensive experiences in bilateral and regional economic and trade cooperation. He graduated from the University of International Business and Economics and served as visiting scholars in Trade and Development Institute (Ireland), Manchester University (UK) and Boston University (USA) respectively in his early career.

Justin Leong

President
Asia & Latin America
ResMed

Justin Leong was appointed president of ResMed’s Asian and Latin American markets in June 2020, an extension of his role as president of ResMed’s Asia Growth Markets, held since September 2018, and the region’s senior vice president since May 2016. He joined ResMed in 2013 as vice president of Global Strategy, adding the role of General Manager of Greater China in 2015.

Before joining ResMed, Justin was a director at London-based investment firm HgCapital from 2006 to 2012, responsible for acquisitions and portfolio management, and serving on the board of directors of several European healthcare companies. From 1999 to 2004, he was a management consultant with Bain & Co. in Sydney, Boston and New York, where he advised clients on growth strategies, operational improvement projects, mergers and acquisitions.

Justin holds a Bachelor of Commerce and a Bachelor of Laws from the University of New South Wales, Sydney, and a Master of Business Administration from the Harvard Business School.

Rob Linden

Senior Partner
McKinsey & Company